-
Anemia y alteraciones de la coagulación en la insuficiencia renal crónica. Capitulo 66.4. En Nefrología Clínica.
Cases A.
4ª Edición. Arias M ed. Editorial Medica Panamericana S.A. Madrid, 2014. pp 893-904.
-
Ver
The iron cycle in CKD: from genetics and experimental models to CKD patients.
Zumbrennen-Bullough K, Babitt JL.
Nephrol Dial Transplant. 2013 Nov 13.
-
Ver
KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.
Kliger AS, Foley RN, Goldfarb DS, Goldstein SL, Johansen K, Singh A, Szczech L.
Am J Kidney Dis. 2013 Nov;62(5):849-59.
-
Ver
Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis.
Vaziri N.
Am J Kidney Dis. 2013; 61: 992-1000.
-
Ver
Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement.
Locatelli F, Bárány P, Covic A, De Francisco A, Del Vecchio L, Goldsmith D, Hörl W, London G, Vanholder R, Van Biesen W, ERA-EDTA ERBP Advisory Board.
Nephrol. Dial. Transplant 2013; 28: 1346-1359.
-
Ver
Mechanisms of Anemia in CKD.
Babitt JL, Lin HY.
J Am Soc Nephrol. 2012 ; 23: 1631-4.
-
KDIGO clinical practice guidelines for anemia in chronic kidney disease.
Kidney Int (Suppl) 2012; 2:279-335.
-
Ver
Parenteral versus oral iron therapy for adults and children with chronic kidney disease.
Albaramki J, Hodson EM, Craig JC, Webster AC.
Cochrane Database Syst Rev 2012; 1:CD007857.
-
Ver
Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.
Fishbane S, Pollack S, Feldman HI, Joffe MM.
Clin J Am Soc Nephrol 2009; 4: 57-61.
-
Ver
Clinical Aspects of Iron Use in the Anemia of Kidney Disease.
Hörl WH.
J Am Soc Nephrol. 2007; 18: 382-93.